The McGill University Health Centre is one of two major healthcare networks in the city of Montreal, Quebec. It is affiliated with McGill University and is one of the largest medical institutions in Canada. It is the largest hospital system in Canada by bed capacity.

There are 1,379 beds in McGill University Health Centre.

During the past decade, McGill University Health Centre conducted 386 clinical trials. In the 10-year time frame, 386 clinical trials started and 87 clinical trials were completed, i.e. on average, 22.5% percent of trials that started reached the finish line to date. In the past 5 years, 183 clinical trials started and 58 clinical trials were completed. i.e. 31.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McGill University Health Centre" #1 sponsor was "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 113 trials, followed by "McGill University" with 26 trials sponsored, "Pfizer" with 24 trials sponsored, "Boehringer Ingelheim" with 16 trials sponsored and "Janssen Research & Development, LLC" with 16 trials sponsored. Other sponsors include 351 different institutions and companies that sponsored additional 227 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McGill University Health Centre" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 48 trials as a collaborator, "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 27 trials as a collaborator, "University Health Network, Toronto" with 12 trials as a collaborator, "University of Toronto" with 11 trials as a collaborator and "McGill University" with 10 trials as a collaborator. Other collaborators include 480 different institutions and companies that were collaborators in the rest 319 trials.

According to Clinical.Site data, the most researched conditions in "McGill University Health Centre" are "Atrial Fibrillation" (16 trials), "Heart Failure" (12 trials), "Crohn's Disease" (11 trials), "Multiple Myeloma" (11 trials) and "Breast Cancer" (10 trials). Many other conditions were trialed in "McGill University Health Centre" in a lesser frequency.

Most popular intervention types in "McGill University Health Centre" are "Drug" (291 trials), "Other" (102 trials), "Device" (66 trials), "Procedure" (42 trials) and "Biological" (39 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (73 trials), "Pembrolizumab" (8 trials), "Daratumumab" (7 trials), "Apixaban" (6 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "McGill University Health Centre" are 487 trials for "All" genders, 42 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 230 active trials in "McGill University Health Centre". 12 are not yet recruiting, 131 are recruiting, 83 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 211 completed trials in McGill University Health Centre, undefined suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in McGill University Health Centre, 31 "Phase 1" clinical trials were conducted, 117 "Phase 2" clinical trials and 155 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 155 trials that are defined as “Not Applicable".

McGill University Health Centre has several departments that took part in Clinical trials: "Montreal Gen Hosp / Div of Clin Immuno and Allergy" - 7 trials, "McGill University Health Centre-Cedars Cancer Centre" - 41 trials, "Chronic Viral Illness Service - Royal Victoria Hospital - McGill University Health Centre (MUHC)" - 5 trials, "Department of Internal Medicine, Montreal General Hospital" - 2 trials, "Montreal Neurological Hospital Research Pharmacy" - 2 trials